Microsoft sued by software company Veeva over 'Viva' branding

Reuters
02-05
Microsoft sued by software company Veeva over 'Viva' branding

By Blake Brittain

Feb 4 (Reuters) - Pharmaceutical software company Veeva Systems VEEV.N has sued Microsoft MSFT.O in California federal court, alleging Microsoft's Viva business software infringes its trademarks.

Veeva told the courton Monday that Microsoft Viva, a suite of applications for employee communication and engagement, will cause consumer confusion with Veeva's software.

Veeva asked the court to force the tech giant to stop using its Viva branding and requested an unspecified amount of monetary damages.

Spokespeople for Microsoft did not immediately respond to a request for comment on Tuesday. A Veeva spokesperson said the company is confident in its case and looks forward to "resolving the issue."

Pleasanton, California-based Veeva specializes in cloud-based software for the pharmaceutical industry. Its products include software for managing customer relationships, content management and data analysis.

The complaint said that Microsoft offers similar business management and collaboration software under the Viva name. Veeva said Microsoft's similarly named software will cause market confusion, and noted that news articles and transcripts of Microsoft earnings calls have referred to its software as "Veeva."

The case is Veeva Systems Inc v. Microsoft Corp, U.S. District Court for the Northern District of California, No. 3:25-cv-01110.

For Veeva: Morgan Smith and Douglas Rettew of Finnegan Henderson Farabow Garrett & Dunner

For Microsoft: attorney information not yet available

(Reporting by Blake Brittain in Washington)

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10